Showing results (1421-1430 of 1,583) with videos related to

Sort By:
Pageof 159
Clinical and Experimental Rheumatology|February 18, 2014
The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational studyR Westhovens, R F van Vollenhoven, D T Boumpas, et al.
Hepatology (Baltimore, Md.)|April 7, 2022
Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalizationMaika S Deffieu, Camille M H Clément, Cristina M Dorobantu, et al.
Iscience|March 19, 2025
Divergent responses to SARS-CoV-2 infection in bronchial epithelium with pre-existing respiratory diseasesJustine Oliva, Manon Ruffin, Claire Calmel, et al.
Molecular Urology|November 4, 2000
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapyM C Gong, S S Chang, F Watt, et al.
Medicine|August 31, 2012
Lupus anticoagulant-hypoprothrombinemia syndrome: report of 8 cases and review of the literatureKarin Mazodier, Laurent Arnaud, Alexis Mathian, et al.
Zeitschrift Fur Orthopadie Und Unfallchirurgie|August 8, 2024
[Cervical Spine Injuries]Max J Scheyerer, Sebastian F Bigdon, Robert Gaudin, et al.
Rice (New York, N.Y.)|April 9, 2024
A Case Study from the Overexpression of OsTZF5, Encoding a CCCH Tandem Zinc Finger Protein, in Rice Plants Across Nineteen Yield TrialsAlexandre Grondin, Mignon A Natividad, Takuya Ogata, et al.
Plos One|February 10, 2011
Control of flowering and cell fate by LIF2, an RNA binding partner of the polycomb complex component LHP1David Latrasse, Sophie Germann, Nicole Houba-Hérin, et al.
Arthritis Research & Therapy|March 13, 2012
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational studyFernando Kemta Lekpa, Cécile Poulain, Daniel Wendling, et al.
Pageof 159